Preoperative PET/CT in earlystage breast cancer: Is the TNM classification enough?

Annals of Oncology

Volumn 24, Issue 3, 2013, Pages 852-

  Gilardi, L ^a   Fumagalli, L ^b   Paganelli, G ^a  

^a Nuclear Medicine Division   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABY 002 GA 68; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FFNP F 18; FLUORODEOXYGLUCOSE; FLUOROESTRADIOL F 18; TRACER; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CLASSIFICATION; CANCER STAGING; CELL SUBPOPULATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; EARLY CANCER; HUMAN; LETTER; LYMPH NODE METASTASIS; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; RECEPTOR AFFINITY; TUMOR CELL LINE; TUMOR VOLUME;

EID: 84874557573     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt004     Document Type: Letter

References (5)

1. Bernsdorf M, Berthelsen AK, Wielenga VT et al.. Preoperative PET/CT in early stage breast cancer. Ann Oncol 2012; 23(9): 2277-2282.
2. Edge SB, Byrd DR, Compton CC et al. AJCC Cancer Staging Handbook, 7th Edition, New York: Springer 2010.
3. Perou CM, Sørlie T, Eisen MB et al.. Molecular portraits of human breast tumours. Nature 2000; 406(6797): 747-752.
4. Goldhirsch A, Wood WC, Coates AS et al.. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22(8): 1736-1747.
5. Basu S, Kwee TC, Gatenby R et al.. Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders. Eur J Nucl Med Mol Imaging 2011; 38(6): 987-991.